Discovery Park Technology Investments (Gp) Ltd investment portfolio

CENTAURI THERAPEUTICS LIMITED develops immunotherapy products that use its proprietary Alphamer® platform to redirect naturally occurring antibodies against life‑threatening infectious diseases and cancers. The company focuses on creating novel molecules that harness a clinically validated immune mechanism to treat Gram‑negative bacterial infections and other high‑impact diseases.

COOMTECH LTD develops and provides a patented kinetic drying technology that mechanically removes surface moisture from bulk solids using aerodynamic turbulence instead of traditional thermal evaporation. Their low-energy system is designed for the aggregates, cement, and mineral industries to process materials such as sand, limestone, and pulverised fuel ash while reducing energy consumption and carbon emissions.